Gemifloxacin

Dosage; Usual; Oral: 320 mg once daily for 5- 10 days

Acute exacerbations of chronic bronchitis: Oral: 320 mg once daily for 5 days

Community-acquired pneumonia (mild-to-moderate): Oral: 320 mg once daily for 5 or 7 days

(decision to use 5- or 7-day regimen should be guided by initial sputum culture;

7 days are recommended for MDRSP, Klebsiella, or M. catarrhalis infection)

Sinusitis (unlabeled use): Oral: 320 mg once daily for 10 days

Gemifloxacin Brands

Brand Name Manufacturer Name Distributor Drug Strength Packaging Formulation Formulation Strength Price
Actigem Ferozsons 7s 320mg KES 750
Gemiflox Popular Pharmaceuticals Ltd Omaera Pharmaceuticals Ltd 10s 320mg KES 938

Gemifloxacin more info

Mode Of Action

interferes with bacterial DNA synthesis by inhibiting topoisomerase II (DNA gyrase) and topoisomerase IV.

Drug Indication ENT, UTI, RTI, skin and soft tissues, bone, joint, GI, intra-abdominal, pelvic and severe infections, gonorrhoea.
Precautions Quinolones should be used with caution in children with a history of epilepsy or conditions that predispose to seizures, in G6PD deficiency, myasthenia gravis (risk of exacerbation). Exposure to excessive sunlight should be avoided (discontinue if photosensitivity occurs). Quinolones may induce convulsions in patients with or without a history of convulsions; taking NSAIDs at the same time may also induce them. May cause arthropathy in the weight-bearing joints of immature animals and are therefore generally not recommended in children and growing adolescents. However, the significance of this effect in humans is uncertain and in some specific circumstances short-term use of a quinolone in children is justified. Should be avoid in pregnancy and lactation.
Contra-Indications History of tendon disorders related to quinolone use, documented hypersensitivity.
Dosage 320mg OD for 5-7 days
Pregnancy Category Category B3
Pregnancy Category Description Drugs which have been taken by only a small number of pregnant women and women of child-bearing age with no any established rise in the frequency of malformations or other direct or indirect detrimental effects on the foetus having been noted. Studies in animals show evidence of an increased occurrence of foetal damage, the significance of which is uncertain in human
Drug Category DRUGS ACTING ON INFECTIONS
Drug Sub-Category Fluoroquinolones

Moxifloxacin more information